Bluprint Oncology - Powered by Petauri™ - passionate about your scientific story – from ASCO to X, our mission is to identify and define a story that resonates.
Last night we received the Dorothy Schachne Corporate Achievement Award at @CancerCare’s Gala.
We truly value our collaboration with CancerCare on the @myTRIAList initiative. The road ahead is clear: better outcomes, better access, better experiences.
#Oncology#CancerResearch
📢 Accepted at @ASCO!
We’re honored to be recognized as a co-author on @CancerCare’s @myTRIAList#ASCO25 abstract which focuses on the reach and utilization of the myTRIAList trial finder.
Connect with our team at ASCO to learn more about myTRIAList sponsorship opportunities!
Big news! myTRIAList's abstract on expanding clinical trial access has been accepted for publication by @ASCO!
📲 Scan the QR to explore the research, and DM us to see how myTRIAList helps to educate and connect patients with the right cancer #clinicaltrials.
#ASCO25#Oncology
Reflecting on years of ASCO memories and getting ready to make new ones at this year’s @ASCO meeting! Will you be attending #ASCO25? Let’s connect! DM us to schedule a time to meet with our team of scientific experts to discuss how we can elevate your science.
#ASCO#Oncology
Our team is incredibly humbled to join @ASCO as a fellow honoree at this year’s @CancerCare Gala!
Every day, we bring our best— because we believe better access, better outcomes, and better patient experiences aren’t optional; they’re essential.
#Oncology#CancerCare
We’re proud to honor @ASCO, Bluprint Oncology and @PetauriHealth at this year’s gala for their substantial contributions to help improve the lives of people affected by cancer. Learn more about our upcoming gala here: https://t.co/Z2QXI9hGRk
Reflecting on an impactful week at ASCO GI🔬
The advancements presented this week are pushing the boundaries of science and clinical care. We’re grateful for our team and their commitment to supporting our clients at #GI25!
#ASCO#Oncology#OncTwitter@ASCO
Happy New Year, everyone! 🎉
As we enter 2025, we thank all our friends, clients, and colleagues for their unwavering support and collaboration. Last year was filled with incredible achievements and growth, and we're excited about the opportunities and challenges that lie ahead!
We’re having an incredible time connecting with clients and engaging in insightful sessions at @ASH_hematology's annual meeting!
What sessions or moments have been the most impactful for you so far?
#ASH24#hematology#research#patientcare
What an unforgettable #SITC24!
The latest updates in #Cancer immunotherapy presented last week at @sitcancer's annual meeting left us inspired and optimistic for the future of #PatientCare. A big congratulations to our team on another successful SITC!
#Immunotherapy#Research
Abstract submissions for the @ASCO annual meeting are open! Our team is ready to support you in your abstract development. DM us and meet with our team to explore what we can accomplish together to ensure your #CancerResearch makes an impact at #ASCO25!
#medcomms#OncTwitter
#ASCO25 is the place to be heard! Now accepting abstracts until Jan. 28. This is your chance to share your scientific discoveries on the largest global oncology stage. View submission resources & submit today: https://t.co/mPkueTl89K
Will you be at the @sitcancer annual meeting this week?
Our scientific team will be on-site, helping clients drive success. Let’s connect to explore how we can collaborate and elevate your scientific research!
#SITC#SITC24#Immunotherapy#Oncology#Hematology#Pharma
Agility, adaptability, and excellence— Some of the many words that describe our #ProjectManagement team.
Our innovative approaches ensure we consistently exceed clients’ expectations. DM us to discover how we can help accelerate your scientific efforts!
#oncology#medcomms
Bluprint Oncology offers scalable, strategic, and impactful ways to reach your audiences!
Read about how our team can amplify your science during the upcoming congress seasons⬇️